Claudin 6 Bispecific Antibody(Context Therapeutics)

N/A

Report date: 2026/03/19 17:22:41

Base Information

Drug NameClaudin 6 Bispecific Antibody(Context Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CLDN6Anti-CD3

TargetsClaudin 6T cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesContext Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesContext Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A